Nirmatrelvir and ritonavir combination is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk for progression to severe COVID-19 (eg, hospitalization, death). This medicine is available only with your doctor’s prescription.
| Strength | 150 mg + 100 mg |
| Packaging size | 20 + 10 Tablet |
| Compostion | Nirmatrelvit and Ritonavir |
| Prescription/Nonprescription | Prescription |
| Form | Tablet |
| Brand Name | Combovir |
| Manufacturer | Bruck |
| Shelf Life | 2 Year |
| Country of origin | Made in India |
Nirmatrelvir and ritonavir combination is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk for progression to severe COVID-19 (eg, hospitalization, death). This medicine is available only with your doctor’s prescription.
| Strength | 150 mg + 100 mg |
|---|---|
| Packaging size | 20 + 10 Tablet |
| Compostion | Nirmatrelvit and Ritonavir |
| Prescription/Nonprescription | Prescription |
| Form | Tablet |
| Brand Name | Combovir |
| Manufacturer | Bruck |
| Shelf Life | 2 Year |
| Country of origin | Made in India |
Reviews
There are no reviews yet.